Tag: Vaccines
Lower Risk of COVID-19 in Infants With Vaccination During Pregnancy
Infants of vaccinated mothers had reduced risk of a positive test; risk was lower during delta versus omicron period
Vaccination Offers Partial Protection for Postacute Phase of COVID-19
Individuals with breakthrough infection have increased risk for death, postacute sequelae compared with contemporary controls
Antibody Levels After COVID-19 Vaccination Inversely Linked to Body Weight
Inverse correlation sustained for up to six months following two doses of BNT162b2 in small cohort of healthy young and middle-aged adults
Vaccination After SARS-CoV-2 Infection May Cut Long COVID Risk
Initial decrease in odds for long COVID seen after first vaccine dose with evidence suggesting sustained improvement after second dose
Three-Dose Pfizer Vaccine Spurs Strong Response in Youngest Children
Company says third dose gave the young children 80 percent protection against asymptomatic COVID-19
CDC Advisers Recommend Pfizer Booster Shot for Children 5 to 11
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
Rollout of Pfizer COVID-19 Vaccine Saved Lives, Health Care Dollars
Model shows vaccine tied to prevention of 110,000 deaths and a resulting $30.4 billion direct health care cost savings
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients
